HIGHLIGHTS
- who: Kang Li and colleagues from the Medical School of Nanjing University, Nanjing, Jiangsu, China, Core Laboratory, Sir Run Run Hospital have published the paper: Clinical implication and potential function of ARHGEF6 in acute myeloid leukemia: An in vitro study, in the Journal: PLOS ONE of 29/04/2022
- what: The research showed that the expression of ARHGEF6 was mainly higher in AML cell lines meanwhile was highest in the samples from patients with AML compared to other cancer types.
- how: The result showed that AML patients with t(821) had the highest . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.